NOVACYT

Euronext Growth Paris
FR0010397232 - Stock

CAC 40 0.51% SBF 120 0.47% EUR / USD -0.13% GROWTH ALL -0.13%

0.731
Last traded price
09/01/2025 - 17:35  CET
ORDERS ACCUMULATION (CALL)
Since Open
+0.013 (+1.81%)
Since Previous Close
+0.015 (+2.09%)
Valuation Close
0.731
09/01/2025 - 17:55  CET
Theoretical Opening Price 0.75    
10/01/2025 - 08:19  CET

Company profile

Novacyt develops, produces, and sells in vitro and molecular diagnostic products for the microbiology, haematology and serology markets. The activity is organized around two sectors:
  • development of solutions and diagnostic services. The group is also developing a manufacturing activity for reagents and kits for bacterial and blood tests;
  • manufacture and sale of molecular screening kits (Primerdesign): for laboratories.

Source: Cofisem - Last Update: 17 Nov 2024
Key Executives
Chief Executive Officer Lyn Rees
Chief Financial Officer Steve Gibson
Company Secretary Steve Gibson
Source: Cofisem - Last Update: 17 Nov 2024
Key figures
Millenium 2023 2022 2021 2020 2019
Net sales 11.579 21.040 95.780 277.204 11.468
Income from ordinary activities 11.579 21.040 95.780 277.204 11.468
Operating income -29.516 -23.393 -7.795 167.441 -1.556
Cost of financial indebtedness net -53 -321 -147 1.601 0
Equity-accounted companies contribution to income
Net profit from discontinued activities -492 -3.529 -2.330
Net income -28.292 -25.730 -9.728 132.423 -5.749
Net income (Group share) -28.292 -25.730 -9.728 132.423 -5.749
Fiscal year end 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit GBP - thousands GBP - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards IFRS IFRS IFRS IFRS IFRS
Source: Cofisem - Last Update: 17 Nov 2024
Shareholder information
Biosynex 2,50 %
Source: Cofisem - Last Update: 17 Nov 2024

Address

Novacyt

13 Avenue Morane Saulnier
FR-78140 Vélizy-Villacoublay
France
Source: Cofisem - Last Update: 17 Nov 2024

Contact

Mandy Cowling
Phone number: + 44 (0)7785541259
Source: Novacyt - Last Update: 17 Nov 2024